David Zanoni
Momentum, growth at reasonable price, long-term horizon

Skystar Bio Pharmaceutical Company: Undervalued With A Strong Growth Catalyst

Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) represents an interesting potential investment opportunity. The company provides niche products for China's animal husbandry industry. Skystar aims to provide products that improve profitability and efficiency for small and medium-sized animal farmers. China has become the second largest country after the U.S. for the consumption of animal health products. Skystar stands to benefit since the veterinary medicine industry in China is growing by 15% annually. By the end of 2013, Skystar had over 4,000 customers in 29 provinces in China.

The company operates four product lines. The veterinary medicine line is the largest product line as it comprised 60% of 2013 revenue. Skystar's veterinary medicine line has over 145 products for poultry and...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details